glp 1 agonists and sglt2 inhibitors combination GLP-1 Receptor Agonist Therapy With Without in Patients With Type 2 Diabetes Full article: Combination SGLT2 inhibitor

14,15 Another meta-analysis of 93 clinical trials showed that GLP-1 RAs increased the risk of early-stage DR compared with placebo, with this effect being driven by albiglutide in particular

Though often covered by insurance, newer GLP-1 medications are often much more expensive than other glucose-lowering medications like sulfonylureas, metformin, and thiazolidinediones

(2019) further verified our results by animal experiment

[DOI] [PMC free article] [PubMed] [Google Scholar] 36.Li X., Liu Y., Zheng Y., Wang P., Zhang Y

doi:10.1016/s0140-6736(02)09335-2 12

Therefore, it is unsurprising that the discovery and development of gastrointestinal hormone co-agonists as a pharmacological therapy has transformed the treatment of obesity